Cargando…

Xuanfei Baidu Decoction regulates NETs formation via CXCL2/CXCR2 signaling pathway that is involved in acute lung injury

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening symptoms in Coronavirus Disease 2019 (COVID-19) patients. Xuanfei Baidu Decoction (XFBD) is a recommend first-line traditional Chinese medicine (TCM) formula therapeutic strategy for COVID-19 patients. Prior...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Mengen, Liu, Yiman, Qin, Honglin, Shang, Ting, Xue, Zhifeng, Yang, Shuang, Zhang, Han, Yang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Masson SAS. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019344/ https://www.ncbi.nlm.nih.gov/pubmed/36933379 http://dx.doi.org/10.1016/j.biopha.2023.114530

Ejemplares similares

Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2021)

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2022)

Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms
por: Meng, Tiantian, et al.
Publicado: (2023)

Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
por: Wang, Yuying, et al.
Publicado: (2022)

Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
por: Wang, Yuying, et al.
Publicado: (2022)

Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats
por: He, Qiaoyu, et al.
Publicado: (2022)

Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial
por: Xiong, Wu-zhong, et al.
Publicado: (2020)

Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics
por: Xiong, Li, et al.
Publicado: (2022)

Efficacy and safety of Xuanfei Baidu granules for treating COVID-19: A protocol for systematic review and meta-analysis
por: Zhao, Jisen, et al.
Publicado: (2021)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 M(pro)
por: Zhang, Min, et al.
Publicado: (2023)

Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy
por: Li, Yujia, et al.
Publicado: (2021)

Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway
por: Zhu, Yanru, et al.
Publicado: (2023)

Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway
por: Li, Caixia, et al.
Publicado: (2023)

Screening out anti-inflammatory or anti-viral targets in Xuanfei Baidu Tang through a new technique of reverse finding target
por: Wang, Zixuan, et al.
Publicado: (2021)

The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Li, Fan, et al.
Publicado: (2021)

Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
por: Li, Zhenhao, et al.
Publicado: (2023)

Qinwen Baidu decoction for sepsis: A protocol for a systematic review and meta-analysis
por: Wang, Ping, et al.
Publicado: (2019)

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
por: Werner, Lael, et al.
Publicado: (2013)

Bioactive Components from Qingwen Baidu Decoction against LPS-Induced Acute Lung Injury in Rats
por: Zhang, Qi, et al.
Publicado: (2017)

Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

Simiao Qingwen Baidu decoction inhibits Epstein–Barr virus-induced B lymphoproliferative disease and lytic viral replication
por: Yang, Xianhui, et al.
Publicado: (2021)

CXCL1/CXCR2 is involved in white matter injury in neonatal rats via the gut–brain axis
por: Yang, Can, et al.
Publicado: (2022)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
por: Han, Zhi-Jian, et al.
Publicado: (2021)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
por: Wen, Jianxia, et al.
Publicado: (2020)

CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
por: Da, Zhanyun, et al.
Publicado: (2016)

Anti-inflammatory or anti-SARS-CoV-2 ingredients in Huashi Baidu Decoction and their corresponding targets: Target screening and molecular docking study
por: Wang, Zixuan, et al.
Publicado: (2023)

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
por: Yang, Yaru, et al.
Publicado: (2023)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods
por: Zhu, Yi-Wei, et al.
Publicado: (2021)

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
por: Xu, Haiyu, et al.
Publicado: (2023)

CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma
por: Xin, Qi, et al.
Publicado: (2017)

Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
por: Huang, Yu, et al.
Publicado: (2013)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
por: Xue, Xiaoming, et al.
Publicado: (2021)

Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
por: ZHU, XIAOLI, et al.
Publicado: (2016)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing
por: Mühlethaler-Mottet, Annick, et al.
Publicado: (2015)

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
por: Ha, Helen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vt8blgn9jsamhnsq7r01o05ghi